Department of Cardiology, Lorestan University of Medical Sciences, Khoramabad, Iran.
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Biomed Pharmacother. 2017 Feb;86:316-323. doi: 10.1016/j.biopha.2016.12.009. Epub 2016 Dec 21.
Nanoliposomes are type of nano-sized vesicles made of bi-layered phospholipid membranes with an aqueous interior. They have been demonstrated to deliver several materials like low molecular weight drugs, imaging agents, peptides, proteins, and nucleic acids. Nanoliposomes have been demonstrated to slowly release an encapsulated drug, thereby leading to sustained exposure to target region and improved efficacy. This ability of nano-liposomes can be harnessed to deliver therapeutic agents precisely to the infarcted heart. Accordingly, this article will review recent developments in the application of nano liposomes and nanoparticles as drug delivery systems to treat cardiovascular related disorders such as atherosclerosis, restenosis and myocardial infarction.
纳米脂质体是一种由双层磷脂膜组成的纳米级囊泡,内部为水相。已证实,纳米脂质体可递送多种物质,如小分子药物、成像剂、肽类、蛋白质和核酸。纳米脂质体可使包封的药物缓慢释放,从而使靶区持续暴露于药物并提高疗效。纳米脂质体的这种能力可用于将治疗剂精确递送至梗死的心脏。因此,本文将综述纳米脂质体和纳米颗粒作为药物递送系统在治疗心血管相关疾病(如动脉粥样硬化、再狭窄和心肌梗死)中的应用的最新进展。